Theratechnologies Inc T.TH

New asset opportunities

[palinc2000]

I would assume that the mention of new asset opportunities is based on more than a wish... ongoing discussions?

• FY2023 operating plan to focus on achieving positive EBITDA1 in the near-term based on commercial business growth and new asset opportunities 

•  
• FY2023 operating plan to focus on achieving positive EBITDA1 in the near-term based on commercial business growth and new asset opportunities
• FY2023 operating plan to focus on achieving positive EBITDA1 in the near-term based on commercial business growth and new asset opportunities

[Joemare]

Unfortunately, not a trust-worthy statement to put on a corporate slide.  The China deal, remember.  Until they walk the talk, these so-called executives will not have the trust of the markets.  Until they come up with a decent strategy on their sortilin-plateform, they won't be taken seriously on their clinical development skill set. Until they figure out a plan with

[Trogarzon]

And for the modest sum of 2M a year salary... in plain english... what has a new CEO acheived in the pas 36 months... and now we need Luc again.. so save the face of the company by managing leen.  

[SPCEO1]

When the proxy comes out this year, the salary, options awards and bonus info is going to be interesting reading. Given the company's year-end was 11/30 and the TH-1902 trial pause came the next day, TH may have already committed to paying bonuses and salaries it may not have committed to if they knew the pause was going to happen ahead of time. Obviously, there is a lot of potential for

[Garp1]

Patehtic maybe, but certainly not interesting.

[SABBOBCAT]

Any company I have been a part of does not decide on or grant bonuses until after the year ends, so the few days of timing should be irrelevant. However with that being said, they did switch thier option granting logic a while ago so I am curious.  Considering that there were trial delays and other issues, it will be shocking if full bonuses are dolled out anywhere.   

[Wino115]

Given developments, I'm fine with having all senior managers aligned to seeing shareholder returns for comp - in fact, I'd cut cash and give them more options even at this low price. I want a huge incentive to do whatever they can to claw there way back to $300mil+ valuation given revenues are projected for close to $100m and growing.  I wouldn't count too much on the tuck-in